scholarly article | Q13442814 |
P50 | author | Andrew Boulle | Q53680127 |
Michael Schomaker | Q56517250 | ||
Barbara Rusch | Q117269827 | ||
Iza Ciglenecki | Q117269828 | ||
P2093 | author name string | Welile Sikhondze | |
Bernhard Kerschberger | |||
Alex Telnov | |||
Lorraine Pasipamire | |||
Debrah Vambe | |||
Nicholas Kisyeri | |||
Siphiwe Mavis Ngwenya | |||
P2860 | cites work | Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults | Q24200879 |
Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis | Q26798435 | ||
A systematic review of published literature describing factors associated with tuberculosis recurrence in people living with HIV in Africa | Q28387848 | ||
Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa | Q28533713 | ||
Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa | Q28547001 | ||
Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis | Q28657913 | ||
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study | Q29615717 | ||
Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis | Q30245603 | ||
Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013. | Q30378028 | ||
The rise and fall of tuberculosis in Malawi: associations with HIV infection and antiretroviral therapy. | Q30385976 | ||
Sexual inequality in tuberculosis | Q33520199 | ||
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources | Q42977188 | ||
The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting | Q44674242 | ||
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study. | Q47121800 | ||
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study | Q47202008 | ||
Recent advances in tuberculosis diagnostics in resource-limited settings. | Q52575510 | ||
The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. | Q52623018 | ||
Challenges and successes in the implementation of option B+ to prevent mother-to-child transmission of HIV in southern Swaziland. | Q52646486 | ||
Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi | Q62494420 | ||
Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region | Q64357339 | ||
Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat-all approach in rural Eswatini | Q92777740 | ||
A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa | Q33813159 | ||
Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community | Q34222186 | ||
Antiretroviral therapy for tuberculosis control in nine African countries | Q34320245 | ||
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis | Q34387168 | ||
Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in Brazil | Q34429881 | ||
The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study | Q34447727 | ||
Migration and AIDS. | Q34892196 | ||
Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis | Q34999621 | ||
Recent patterns in population-based HIV prevalence in Swaziland | Q35021677 | ||
Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland | Q35103348 | ||
Implementation and Operational Research: Barriers and Facilitators to Combined ART Initiation in Pregnant Women With HIV: Lessons Learnt From a PMTCT B+ Pilot Program in Swaziland | Q35566705 | ||
Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. | Q35584415 | ||
Completeness and Reliability of the Republic of South Africa National Tuberculosis (TB) Surveillance System | Q35741687 | ||
Declining tuberculosis notification trend associated with strengthened TB and expanded HIV care in Swaziland | Q35805029 | ||
The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study | Q35846261 | ||
Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa | Q35850330 | ||
Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling study | Q36003735 | ||
Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis | Q36096194 | ||
Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic study | Q36183133 | ||
Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial | Q36246188 | ||
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment | Q36424963 | ||
Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy | Q36514050 | ||
High mortality in tuberculosis patients despite HIV interventions in Swaziland | Q37020503 | ||
Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi | Q37023865 | ||
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa | Q37240761 | ||
Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community | Q37240770 | ||
Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe | Q37279224 | ||
Five years retrospective cohort analysis of treatment outcomes of TB-HIV patients at a PEPFAR/DOTS Centre in South Eastern Nigeria | Q37418344 | ||
Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact | Q37514147 | ||
Possible misdiagnosis of HIV associated lymphoma as tuberculosis among patients attending Uganda Cancer Institute | Q37700895 | ||
Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012. | Q38855709 | ||
Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis | Q38991491 | ||
Multiple imputation using chained equations: Issues and guidance for practice | Q39513291 | ||
Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions | Q39747436 | ||
P433 | issue | 9 | |
P921 | main subject | Eswatini | Q1050 |
P304 | page(s) | 1114-1127 | |
P577 | publication date | 2019-08-07 | |
P1433 | published in | Tropical Medicine and International Health | Q15765747 |
P1476 | title | Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysis | |
P478 | volume | 24 |